Multiomic predictors for regression of cirrhosis: Clinical implications and future directions.
作者信息
Li Binghua, Yu Decai
机构信息
Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
出版信息
ILIVER. 2024 Sep 7;3(4):100116. doi: 10.1016/j.iliver.2024.100116. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
Multiomic predictors for regression of cirrhosis: Clinical implications and future directions.
ILIVER. 2024 Sep 7;3(4):100116. doi: 10.1016/j.iliver.2024.100116. eCollection 2024 Dec.
2
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.
Sci Transl Med. 2024 Nov 6;16(772):eadh9940. doi: 10.1126/scitranslmed.adh9940.
3
Diagnostic screening of COVID-19 based on multiomics data by high-resolution mass spectrometry (MALDI (+)-TOF MS and ESI(±)-Orbitrap MS).
Metabolomics. 2025 Jun 29;21(4):94. doi: 10.1007/s11306-025-02299-z.
4
Differentially abundant proteins, metabolites, and lipid molecules in spaghetti meat compared to normal chicken breast meat: Multiomics analysis.
Poult Sci. 2025 Jul;104(7):105165. doi: 10.1016/j.psj.2025.105165. Epub 2025 Apr 14.
5
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.
Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2.
6
Multiomics reveals metformin's dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention.
Sci Rep. 2025 Jul 2;15(1):22699. doi: 10.1038/s41598-025-07557-7.
7
Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial.
Diabetes Care. 2025 Jun 30. doi: 10.2337/dc25-0728.
8
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis.
JHEP Rep. 2025 Mar 20;7(6):101398. doi: 10.1016/j.jhepr.2025.101398. eCollection 2025 Jun.
9
Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions.
Clin Ther. 2021 Mar;43(3):500-517. doi: 10.1016/j.clinthera.2021.01.021. Epub 2021 Feb 12.
10
Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia.
Sci Rep. 2025 Jul 1;15(1):20658. doi: 10.1038/s41598-025-06272-7.
本文引用的文献
1
Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression.
J Hepatol. 2024 Dec;81(6):983-994. doi: 10.1016/j.jhep.2024.06.028. Epub 2024 Jun 27.
2
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events.
Clin Gastroenterol Hepatol. 2024 Mar;22(3):591-601.e3. doi: 10.1016/j.cgh.2023.11.017. Epub 2023 Nov 30.
3
Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.
Hepatology. 2024 Feb 1;79(2):289-306. doi: 10.1097/HEP.0000000000000553. Epub 2023 Aug 7.
4
A review of liver fibrosis and cirrhosis regression.
J Pathol Transl Med. 2023 Jul;57(4):189-195. doi: 10.4132/jptm.2023.05.24. Epub 2023 Jun 20.
5
Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies.
Mol Aspects Med. 2023 Aug;92:101191. doi: 10.1016/j.mam.2023.101191. Epub 2023 May 24.
6
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression.
Cells. 2021 Oct 15;10(10):2759. doi: 10.3390/cells10102759.
7
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.
Hepatology. 2022 May;75(5):1235-1246. doi: 10.1002/hep.32204. Epub 2022 Feb 7.
8
Molecular and cellular mechanisms of liver fibrosis and its regression.
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):151-166. doi: 10.1038/s41575-020-00372-7. Epub 2020 Oct 30.
9
Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
J Gastroenterol Hepatol. 2019 Apr;34(4):755-763. doi: 10.1111/jgh.14498. Epub 2018 Nov 8.
10
Fibrosis in chronic liver diseases: diagnosis and management.
J Hepatol. 2005;42 Suppl(1):S22-36. doi: 10.1016/j.jhep.2004.12.008. Epub 2004 Dec 24.
Zotero 插件